MIRM
Mirum Pharmaceuticals Inc
NASDAQ: MIRM · HEALTHCARE · BIOTECHNOLOGY
$107.16
+4.11% today
Updated 2026-05-08
Market cap
$6.28B
P/E ratio
—
P/S ratio
12.04x
EPS (TTM)
$-13.60
Dividend yield
—
52W range
$43 – $112
Volume
0.9M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A5.8
Quality
C+2.0
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
0.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$138.18
+28.95%
12-Month target
—
—
Intrinsic (DCF)
$189.03
Margin of safety
+47.16%
3 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 49.80% QoQ
+ 47.16% below intrinsic value
Risks
- Altman Z 0.18 — distress zone
- Thin margins at -4.48%
- Negative free cash flow $-229.43M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $77.06M | $186.37M | $336.89M | $521.31M | $521.31M |
| Net income | $-135.66M | $-163.41M | $-87.94M | $-23.36M | $-790.15M |
| EPS | — | — | — | — | $-13.60 |
| Free cash flow | $-120.41M | $-91.05M | $9.33M | $54.87M | $-229.43M |
| Profit margin | -176.05% | -87.68% | -26.10% | -4.48% | -4.48% |
Peer comparison
Smart narrative
Mirum Pharmaceuticals Inc trades at $107.16. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.18, it sits in the distress. TTM revenue stands at $521.31M. with profit margins at -4.48%. Our DCF model estimates intrinsic value at $189.03.
Frequently asked questions
What is Mirum Pharmaceuticals Inc's stock price?
Mirum Pharmaceuticals Inc (MIRM) trades at $107.16.
Is Mirum Pharmaceuticals Inc overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell). DCF value $189.03.
What is the price target of Mirum Pharmaceuticals Inc (MIRM)?
The analyst target price is $138.18, representing +28.9% upside from the current price of $107.16.
What is the intrinsic value of Mirum Pharmaceuticals Inc (MIRM)?
Based on our DCF model, intrinsic value is $189.03, a +47.2% margin of safety versus $107.16.
What is Mirum Pharmaceuticals Inc's revenue?
TTM revenue is $521.31M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
0.18 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio12.04x
ROE-8.65%
Beta0.52
50D MA$93.78
200D MA$80.74
Shares out0.06B
Float0.05B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—